Neurodegenerative diseases (ND) such as AD and Parkinson’s disease (PD) were enriched in the KEGG according to network pharmacology and proteomics, so we inferred that ALL may act on the CX3CL-CX3CR1 axis and suppress neuroinflammation to achieve neuroprotection. This evidence concerns the gene CX3CR1 and neurodegenerative disease.